Home/Filings/4/0001181431-11-053816
4//SEC Filing

DRMANAC RADOJE T 4

Accession 0001181431-11-053816

CIK 0001361103other

Filed

Oct 27, 8:00 PM ET

Accepted

Oct 28, 7:45 PM ET

Size

16.1 KB

Accession

0001181431-11-053816

Insider Transaction Report

Form 4
Period: 2011-10-27
DRMANAC RADOJE T
Chief Scientific Officer
Transactions
  • Exercise/Conversion

    Common Stock, $0.01 par value

    2011-10-27$1.50/sh+50,000$75,00080,000 total
  • Disposition to Issuer

    Common Stock, $0.001 par value

    2011-10-27$5.26/sh10,000$52,609108,666 total(indirect: By Trust)
  • Gift

    Common Stock, $0.01 par value

    2011-10-2780,0000 total
  • Gift

    Common Stock, $0.01 par value

    2011-10-27+80,000188,666 total(indirect: By Trust)
  • Exercise/Conversion

    Stock Option (right to buy)

    2011-10-2750,000168,501 total
    Exercise: $1.50Exp: 2020-02-23Common Stock (50,000 underlying)
  • Exercise/Conversion

    Common Stock, $0.01 par value

    2011-10-27$1.50/sh+30,000$45,00030,000 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2011-10-2730,00036,666 total
    Exercise: $1.50Exp: 2019-12-27Common Stock (30,000 underlying)
Holdings
  • Common Stock, $0.01 par value

    (indirect: By Corporation)
    13,333
Footnotes (4)
  • [F1]The shares sold were pursuant to a Rule 10b5-1 plan dated March 17, 2011. The transaction was executed in multiple trades in prices ranging from $5.14 to $5.39 inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
  • [F2]These shares are held by the Drmanac Family Trust dated June 21, 2000, Radoje Drmanac, Trustee.
  • [F3]These shares are held by Callida Genomics, Inc., a corporation wholly owned by the Reporting Person and his wife.
  • [F4]The shares vest pursuant to the following schedule: The shares subject to the option vest in 48 successive, equal monthly installments measured from August 12, 2009, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Documents

1 file

Issuer

COMPLETE GENOMICS INC

CIK 0001361103

Entity typeother

Related Parties

1
  • filerCIK 0001055672

Filing Metadata

Form type
4
Filed
Oct 27, 8:00 PM ET
Accepted
Oct 28, 7:45 PM ET
Size
16.1 KB